Sneeden Campbell

R&D

An NHS study of a new cancer blood test holds huge promise, but will not be without its challenges, says Snedden Campbell’s Ivor Campbell.

News

In a handful of strongly-worded warning letters, the FDA is cracking down on sales of unapproved peptides - even if they're labelled for research.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.